CHEK1 and head and neck squamous cell carcinoma: Therefore, inhibitors against cell cycle checkpoint kinases, such as Chk1 and Wee1, have been developed and which is given more importance due to the fact that the majority of HNSCC tumours harbour p53 mutations.